Profil
Dan T.
Sheehan is currently a Vice President at Medtronic, Inc. (Tennessee).
Prior to this, he held Vice President positions at STERIS Corp.
from 1996 to 2002 and Covidien Ventures from 2008 to 2014.
He was also a General Partner at Affinity Capital Management Co. from 2002 to 2008.
Sheehan has also served as a Director at AcuFocus, Inc., AEGEA Medical, Inc., and Microchips Biotech, Inc. Sheehan holds an undergraduate degree from Fordham University and an MBA from The Trustees of Columbia University in The City of New York.
Postes actifs de Dan T. Sheehan
| Sociétés | Poste | Début |
|---|---|---|
Medtronic, Inc. (Tennessee)
Medtronic, Inc. (Tennessee) Medical SpecialtiesHealth Technology Manufactures instruments for spinal surgery | Private Equity Investor | 01/01/2008 |
Anciens postes connus de Dan T. Sheehan
| Sociétés | Poste | Fin |
|---|---|---|
Covidien Ventures
Covidien Ventures Investment ManagersFinance Covidien Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in early stage capital requirements with an investment size of USD 2 - 20 million. Covidien Ventures reorganized its operating segments on January 26, 2015, by Medtronic Plc into a single segment called Covidien Ventures. | Private Equity Investor | 31/12/2014 |
Affinity Capital Management Co.
Affinity Capital Management Co. Investment ManagersFinance Affinity Capital Management invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector including medical devices, biotechnology, healthcare service and healthcare information technology. It provides financing for early-stage capital transactions. | Private Equity Investor | 31/12/2008 |
| STERIS CORP | Private Equity Investor | 31/12/2002 |
AcuFocus, Inc.
AcuFocus, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales ophthalmic medical device | Directeur/Membre du Conseil | - |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Directeur/Membre du Conseil | - |
Formation de Dan T. Sheehan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
STERIS Corp.
STERIS Corp. Medical SpecialtiesHealth Technology Manufactures and supplies equipment for the prevention of infection and contamination | Health Technology |
Affinity Capital Management Co.
Affinity Capital Management Co. Investment ManagersFinance Affinity Capital Management invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector including medical devices, biotechnology, healthcare service and healthcare information technology. It provides financing for early-stage capital transactions. | Finance |
AcuFocus, Inc.
AcuFocus, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales ophthalmic medical device | Health Technology |
AEGEA Medical, Inc.
AEGEA Medical, Inc. Packaged SoftwareTechnology Services Develops application technology that utilizes convective water vapor to treat menorrhagia | Technology Services |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Health Technology |
Medtronic, Inc. (Tennessee)
Medtronic, Inc. (Tennessee) Medical SpecialtiesHealth Technology Manufactures instruments for spinal surgery | Health Technology |
Covidien Ventures
Covidien Ventures Investment ManagersFinance Covidien Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in early stage capital requirements with an investment size of USD 2 - 20 million. Covidien Ventures reorganized its operating segments on January 26, 2015, by Medtronic Plc into a single segment called Covidien Ventures. | Finance |
















